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Abstract — In vitro embryo culture to support In Vitro
Fertilization (IVF) procedures is a well-established but still
critical technique. In the last decade first attempts to use
microfluidic devices in IVF have shown positive results,
enabling to control the culture conditions and to preserve the
quality of the embryos during their development. In this study
we  completed  an  industry  standard  mouse  embryo  assay
(MEA) to exclude potential toxic effects of PDMS.
I. INTRODUCTION
Assisted reproduction technology (ART) concerns the
procedures, interventions and therapies that are used to treat
human infertility. In vitro fertilization (IVF), the most
common and effective type of ART, consists of the removal
of oocytes from the woman's ovaries and their fertilization
with sperm in a laboratory. Once fertilized the developing
embryo is then implanted back in the woman's uterus.
In the biomedical research community ART and IVF are
widely used procedures to generate genetically altered (GA)
mice and large animals as models to study the effects of gene
function and regulation in human disorders and diseases.
Finally, IVF is a key biotechnology used to preserve
endangered animal species and to control breeding and
increase progeny in agriculture.
The implantation rate following IVF (i.e. the percentage
of embryos which successfully implant compared to the
number of transferred embryos) varies with species, but it is
in general suboptimal [3]. Specifically, for humans and for
GA mice, implantation failures are often ascribed to the
difficulties to control and preserve the microenvironment
surrounding the embryo during its development [4].
The culture techniques used to grow mouse embryos in
vitro have changed very little over recent decades. The most
common method consists of culturing groups of embryos in
Petri dishes in drops of 20 to 100 PL of defined culture
medium, covered by mineral or paraffin oil to avoid
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evaporation. In the last decade, microfluidic miniaturized
platforms have been designed and proposed as innovative
systems to support IVF procedures. This new culture strategy
aims to reduce the invasive handling of medium and 1 cell
zygotes during the 3.5 days of preimplantation embryo
development in vitro, to limit the amount and the
consumption of medium, and to mimic the natural fluid flow
that draws the zygotes through the fallopian tube to the site of
implantation in the uterus. These new culture systems
(discussed in Section II and summarized in Table I) have
shown advantages, such as the reduction of culture medium
volumes, the control of fluid with mL accuracy [5] and the
compatibility with optical and fluorescent imaging. Some of
these systems even support improved quality of the mouse
embryos in terms of cleavage rate (defined as the number of
embryos completed first cell division occurring at 24 hours),
blastocyst rate (i.e number of blastocysts at 72 hours) and
increased implantation rate.
Being derived using microfabrication processes, the first
microfluidic devices were constructed with materials
typically used in microelectronics, such as silicon,
borosilicates, glass or thermoplastic materials, such as
Poly(methyl methacrylate) (PMMA) [6] and polycarbonate
(PC) [7]. With the advent of soft lithography [8] and rapid
prototyping techniques [9], elastomers like
polydimethylsiloxane (PDMS) have become the main
fabrication material for prototyping of microscale devices in
research and industry [7]. PDMS is known for its ease of use
(simple curing process and design adaptability), optical
transparency, gas permeability and biocompatibility but also
for  limitations and adverse effects, such as deformation,
evaporation, small molecules absorption, leaching of uncross
linked oligomers, and hydrophobic recovery [7].
We report in the following section some examples of
PDMS-based microfluidic devices that support in vitro
culture and development of mouse embryos. However, as
result of this review, the specific toxicity of PDMS on
embryo development has never been directly assessed.
In order to better evaluate the potential translation of
these systems to human embryology and IVF, we evaluate
here the toxicity of the PDMS by using a Mouse Embryo
Assay (MEA) that represents the industrial gold standard for
the evaluation of material compatibility.
II. MICROFLUIDIC DEVICES FOR EMBRYO CULTURE
Microfluidic culture systems could potentially support
most parts of an ART cycle in a closed system which could
reduce handling, stress and human error. Gamete selection,
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IVF and development [10][11] have been successfully
performed in  microfluidic systems. “Tab.1” summarizes the
key-features offered by recently developed microfluidic
devices for in vitro embryo culture reported in the literature.
Research groups working in this area have demonstrated that
microfluidic devices can be used to successfully culture
mouse embryos, with the final goal of applying this approach
for mouse breeding or even used in human ART. The
approaches used vary from embryo culture in microchannels
[11][12], to embryo culture in microchambers [12]–[15],
secured in place through the use of wall-like structures or
valves [12][15]. Culture conditions change from device to
device such that: embryos are either cultured individually
[12] or in groups [12][15][16][17], and the volume of
medium is reduced from the standard 20-100 PL to 0.01 to 10
µL. Cultures are performed using single step media with
[13][17] and without [10][16] refreshment, in dynamic or
static conditions respectively. Unfortunately, the majority of
these devices still require the use of mineral oil [10][16][17]
to stabilize temperature, osmolality and pH. Quality and
composition of the oil have been correlated with embryo
cleavage (to morula and blastocyst stages) and embryo
viability [18] that are both markers of embryo developmental
competence rate.
III. MOUSE EMBRYO ASSAY IN MICROFLUIDICS
The MEA is currently the gold standard bioassay used in
research and industry to evaluate the toxicity of any
compound or device that may be exposed to embryos. New
materials, devices or culture media are screened with this test.
Similarly, samples from different batches of products (e.g.
plastic dishes, flask, or pipettes) are regularly tested after
manufacture. The MEA is thus designed to ensure consistent
quality, reliability and safety of products (media or devices)
to be used in assisted conception clinics and it represents the
TABLE I.  EXAMPLES OF MICROFLUIDIC DEVICES FOR IN VITRO CULTURE OF MOUSE EMBRYOS
Research
group
Raty  et  al.,  2004
[16]
Melin et al., 2009
[15]
Heo et al., 2010
[17]
Ma et al., 2011
[10]
Esteves et al., 2013
[12]
Culture environment
Medium M16
HTF
supplemented
with 10% serum
replacement
KSOM + ½ AA
with D-Glucose
and phenol red
Cat # MR 121-D
KSOM
Į-MEM + 0.2%
w/v BSA + 50µg
mL-1 gentamicin
sulphate
Incubator
conditions
37 °C,
5% CO2
37 °C,
5% CO2, 5% O2,
90% N2
37 °C,
5% CO2 and 20%
O2
37 °C,
5% CO2
37 °C,
5% CO2
Single vs.
group culture
Group culture
(10 embryos)
Group culture
(2
embryo/chamber)
Group culture
(13 – 15 embryos)
4x4 array of single
embryos
Single and
group culture
(5 and 20 embryos)
Device characteristics
Volume 10 µl 0.1 µ l 10 µl 0.5 – 10 µl 0.030 and 0.270µl
Material
Silicon/borosilicat
e
PDMS/borosilicate
PDMS PDMS-Parylene-PDMS PDMS PDMS
Retrieval Yes No Yes Yes Yes
Culture characteristic
Refreshed
medium No No Yes No Yes
Mineral oil Yes Yes Yes Yes No
Static vs.
dynamic
culture
Static Static
Pulsatile,
peristaltic
pumping
Static Passive pumping
first stepping stone for the adoption of a new product (i.e. a
microfluidic PDMS device) into this field.
The standard MEA consists of monitoring the growth of
mouse embryos in contact with the material or device “under
test” from 1 or 2 pluripotent cells stage to the blastocyst stage
and in assessing embryo morphology and viability at
different time points. Protocols for this qualitative and
quantitative assessment can vary from company to company
(e.g. Vitrolife, Charles River) depending on the complexity,
novelty and stability of the product to be evaluated, the
selection of mouse strain, the number of replicates and/or the
number of analysed end points are usually not consistent
between companies.
IV. MATERIALS AND METHODS
A. Device fabrication
Microfluidic devices were fabricated in PDMS
(Sylgard® 184, Down Corning, MI, USA) using the
standard soft lithography technique [8]. This process
included the fabrication of SU-8 2050 and SU-8 2035 molds
by lithography to form two PDMS layers presenting a 400
nL circular chamber, accessible by two 7.5 mm long lateral
channels. The two layers were assembled using oxygen
plasma treatment (600 mT, 100 W, 40 s). This process
allowed for contamination removal (chemical), oxidation
and activation of the surfaces. Once assembled, the devices
were immediately filled with embryo tested water using
disposable, sterile syringes and stored at 4 °C until use to
preserve hydrophilicity. Before loading embryos and cell
culture medium, the devices were sterilized by exposure to
UV light for 30 min.
B. Murine embryo production
Murine cryopreserved presumptive 1 cell zygotes were
kindly provided by the Mary Lyon Centre (MRC Harwell
Institute, Oxford, UK). These were obtained from mature
murine metaphase II oocyte-cumulus-complexes retrieved
from C57BL/6NTac mice after superovulation and IVF.
Straws containing frozen 1 cell zygotes were held in air for
30 s, and plunged into room temperature water until the
contents had visibly thawed. The straws were cut at the seal
and the plug bisected to push the contents into a 60 mm,
hydrophobic culture dish. Embryos were incubated for 5 min
and washed 2 times in 100 µl drops of M2 medium at 37°C.
Embryos were then washed 3 times in 10 µL microdrops of
pre-equilibrated potassium-supplemented simplex optimized
medium (KSOM) under oil before culture.
The experimental procedures involving animals use
described in this paper were approved by the Institutional
Animal Care and Ethics Committee.
D. Murine embryo culture in microfluidic devices
The microfluidic device was placed inside a 60 mm
MEA tested culture dish and surrounded with 4 mL of
embryo-tested sterile water. Devices were prepared by
flashing the microfluidic chamber with KSOM for 10 times.
10 µL drops of fresh KSOM were added to inlet and outlet
before overnight pre-equilibration at 37°C (5% CO2, 5% O2
in a humidified nitrogen atmosphere). 9 embryos were then
placed in a 10 PL drop in the inlet port of the device and
loaded by using an EZ-grip embryo handling pipette with a
135 µm diameter tip. Media was then drawn through from
the outlet port until all embryos entered the central chamber.
10 PL drops of pre-equilibrated KSOM were then added to
channel inlet and outlet before culture at 37°C under 5%
CO2 in 5% O2 in humidified nitrogen in a MINC bench top
incubator (Fig. 1). Embryo loading was equally successful
and practical using a range of bulb and pipettor embryo
handling devices common to clinical and research ART
laboratories. Embryo cleavage rates were assessed after 24 h
and blastocyst rates were assessed after 120 h of continuous
culture. Embryos were examined under a Nikon
stereomicroscope with Tokai Hit heated stage set to 37 ºC.
Examples of early cleavage (2-8 cell) and blastocyst stage
embryos are shown in Fig. 2.
Figure 1. Experimental set up – Embryo loaded microfludic devices
placed within a 60 mm tested culture dish, in a MINC bench top incubator.
Figure 2. Examples of 2-cell (left) and blastocyst stage (right) embryos
cultured in microfluidic devices (scale bar 50 Pm).
V. RESULTS AND DISCUSSION
A. Mouse embryo assay
Following industrial standard protocols
(www.criver.com), our MEA test compared cleavage and
blastocyst rates (Fig. 3) resulting from 120 h cultures of
groups of 9 embryos cultured in microdrops (1 PL KSOM
per embryo) or in PDMS devices. No significant differences
were found between microdrop and microfluidic device
cultures in terms of cleavage rate (94.7% ± 1.6, n=117
embryos across 13 microdrop cultures vs 94.4% ± 2.5,
n=135 embryos across 15 device cultures) and blastocyst
rate (94.1% ± 1.8 vs 94.3% ± 2.3 respectively).
Microfluidic culture had no effect on embryo
development rates (p = 0.93), and based on this standard test
for embryo toxicity, PDMS was shown to be non-toxic and
not to affect embryo survival (Fig. 2).
Figure 3. MEA – Cleavage rate and Blastocyst rate Microdrop: n=117
embryos across 13 microdrop cultures. Device: n=135 embryos across 15
device cultures.
VI. CONCLUSION
In this study, we evaluated the material toxicity of PDMS
on embryo development, by using an industry standard
MEA. PDMS has so far been assumed to be a biocompatible
plastic for in vitro embryo culture, based on its general
biocompatibility and the positive results obtained by
culturing zygotes in microfluidic devices. Our tests, which
were designed to uniquely observe the PDMS compatibility,
independently from the device characteristics and functions,
excluded detrimental effects of the material on the embryo
quality. Even if the MEA test represents the standard step for
the introduction of novel materials or devices into the
clinical IVF usage, we believe that subjective morphological
assessment of mouse embryos represents a poor indicator of
the developmental competence of the embryos. A complete
and safe screening method should assess the potential effects
or alterations induced by the new methods/materials/devices
on the genetic, epigenetic and metabolic health
characteristics of the embryos in vitro and/or on their
subsequent implantation potential.
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